Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TripSitter Clinic Ltd C.KETA

Alternate Symbol(s):  TSTTF

TripSitter Clinic Ltd. is a Canada-based company. The Company has no active business.


CSE:KETA - Post by User

TripSitter Clinic Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Post by thelordofstockson Dec 20, 2021 4:30pm
57 Views
Post# 34248272

Buy the Dip!

Buy the Dip!
TripSitter may be fairly small at the moment, but that does not under any circumstances mean that they can't get bigger. They are currently trading at slashed sale price just in time for the holidays of $0.31CAD, which is a steal considering the potential market and their current presence within that market. With a market cap of 20 million, Tripsitter has potential to lead the new wave of psychedelic wellness.

I wouldn't miss this dip!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities